|
1
|
van Niekerk CC, van Dijck JAAM and Verbeek
ALM: The impact of histological subtype in developing both ovarian
and endometrial cancer: A longstanding nationwide incidence study.
Eur J Obstet Gynecol Reprod Biol. 221:17–22. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morice P, Leary A, Creutzberg C,
Abu-Rustum N and Darai E: Endometrial cancer. Lancet.
387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yuan A, Chen JJ and Yang PC:
Pathophysiology of tumor-associated macrophages. Adv Clin Chem.
45:199–223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu HL, Bai HS and Pan HX: Correlation
between TAMs and proliferation and invasion of type I endometrial
carcinoma. Asian Pac J Trop Med. 8:643–650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kelly MG, Francisco AM, Cimic A, Wofford
A, Fitzgerald NC, Yu J and Taylor RN: Type 2 endometrial cancer is
associated with a high density of tumor-associated macrophages in
the stromal compartment. Reprod Sci. 22:948–953. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tong H, Ke JQ, Jiang FZ, Wang XJ, Wang FY,
Li YR, Lu W and Wan XP: Tumor-associated macrophage-derived CXCL8
could induce ERα suppression via HOXB13 in endometrial cancer.
Cancer Lett. 376:127–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soeda S, Nakamura N, Ozeki T, Nishiyama H,
Hojo H, Yamada H, Abe M and Sato A: Tumor-associated macrophages
correlate with vascular space invasion and myometrial invasion in
endometrial carcinoma. Gynecol Oncol. 109:122–128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Espinosa I, Catasus L, D' Angelo E, Mozos
A, Pedrola N, Bértolo C, Ferrer I, Zannoni GF, West RB, van de Rijn
M, et al: Stromal signatures in endometrioid endometrial
carcinomas. Mod Pathol. 27:631–639. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mantovani A and Sica A: Macrophages,
innate immunity and cancer: Balance, tolerance, and diversity. Curr
Opin Immunol. 22:231–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O'Brien J, Lyons T, Monks J, Lucia MS,
Wilson RS, Hines L, Man YG, Borges V and Schedin P: Alternatively
activated macrophages and collagen remodeling characterize the
postpartum involuting mammary gland across species. Am J Pathol.
176:1241–1255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pyonteck SM, Akkari L, Schuhmacher AJ,
Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT,
Teijeiro V, et al: CSF-1R inhibition alters macrophage polarization
and blocks glioma progression. Nat Med. 19:1264–1272. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dou F, Huang L, Yu P, Zhu H, Wang X, Zou
J, Lu P and Xu XM: Temporospatial expression and cellular
localization of oligodendrocyte myelin glycoprotein (OMgp) after
traumatic spinal cord injury in adult rats. J Neurotrauma.
26:2299–2311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murray PJ and Wynn TA: Protective and
pathogenic functions of macrophage subsets. Nat Rev Immunol.
11:723–737. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamilton JA: Colony-stimulating factors in
inflammation and autoimmunity. Nat Rev Immunol. 8:533–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kacinski BM: CSF-1 and its receptor in
ovarian, endometrial and breast cancer. Ann Med. 27:79–85. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dun EC, Hanley K, Wieser F, Bohman S, Yu J
and Taylor RN: Infiltration of tumor-associated macrophages is
increased in the epithelial and stromal compartments of endometrial
carcinomas. Int J Gynecol Pathol. 32:576–584. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weigert A, Sekar D and Brune B:
Tumor-associated macrophages as targets for tumor immunotherapy.
Immunotherapy. 1:83–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jinushi M and Komohara Y: Tumor-associated
macrophages as an emerging target against tumors: Creating a new
path from bench to bedside. Biochim Biophys Acta. 1855:123–130.
2015.PubMed/NCBI
|
|
22
|
Komohara Y, Fujiwara Y, Ohnishi K and
Takeya M: Tumor-associated macrophages: Potential therapeutic
targets for anti-cancer therapy. Adv Drug Deliv Rev. 99:180–185.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ruffell B, Affara NI and Coussens LM:
Differential macrophage programming in the tumor microenvironment.
Trends Immunol. 33:119–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeisberger SM, Odermatt B, Marty C,
Zehnder-Fjällman AH, Ballmer-Hofer K and Schwendener RA:
Clodronate-liposome-mediated depletion of tumour-associated
macrophages: A new and highly effective antiangiogenic therapy
approach. Br J Cancer. 95:272–281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duluc D, Delneste Y, Tan F, Moles MP,
Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N, et
al: Tumor-associated leukemia inhibitory factor and IL-6 skew
monocyte differentiation into tumor-associated macrophage-like
cells. Blood. 110:4319–4330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeannin P, Duluc D and Delneste Y: IL-6
and leukemia-inhibitory factor are involved in the generation of
tumor-associated macrophage: Regulation by IFN-γ. Immunotherapy 3
(4 Suppl). S23–S26. 2011. View Article : Google Scholar
|
|
28
|
Kirma N, Hammes LS, Liu YG, Nair HB,
Valente PT, Kumar S, Flowers LC and Tekmal RR: Elevated expression
of the oncogene c-fms and its ligand, the macrophage
colony-stimulating factor-1, in cervical cancer and the role of
transforming growth factor-beta1 in inducing c-fms expression.
Cancer Res. 67:1918–1926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mancino A and Lawrence T: Nuclear
factor-kappaB and tumor-associated macrophages. Clin Cancer Res.
16:784–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biswas SK and Lewis CE: NF-κB as a central
regulator of macrophage function in tumors. J Leukoc Biol.
88:877–884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chambers SK: Role of CSF-1 in progression
of epithelial ovarian cancer. Future Oncol. 5:1429–1440. 2009.
View Article : Google Scholar : PubMed/NCBI
|
